News
Insilico Develops The World’s First Fully AI-Generated Drug
The Abu Dhabi-based company hopes to treat idiopathic pulmonary fibrosis, and has 30 more drugs in the pipeline.
In a busy biotech hub in Abu Dhabi’s Masdar City, Insilico Medicine is pushing the frontiers of science. Under the watchful eye of Latvian-born CEO Dr Alex Zhavoronkov, the company has developed an AI-generated drug to treat idiopathic pulmonary fibrosis (IPF) — a deadly disease of the lungs.
“This AI drug is a major milestone for us and the industry as a whole,” Dr. Zhavoronkov explains. “We can use AI to create lifesaving treatments for new diseases using approaches we haven’t yet considered and do so much more rapidly and efficiently”.
Idiopathic pulmonary fibrosis is characterized by scarring of the lungs and has no known cure. Insilico’s AI drug aims to halt or even reverse the progression of IPF and is currently undergoing Phase 2 clinical trials in the US and China. The success of these trials will pave the way for more in-depth testing, bringing the drug closer to mass market approval.
Insilico’s groundbreaking research was recently published in Nature Biotechnology. It highlights how the company’s AI platform, Pharma.AI, is connecting the dots between fibrosis and aging to drive forward the discovery of a cure.
IPF treatment is just the beginning for Insilico. The company already has a roadmap consisting of over thirty AI-designed drugs, with seven already in clinical patient trials. These include treatments for inflammatory bowel disease, immuno-oncology targets, and even drugs developed using a method that targets a protein in cancers that can kill them without harming healthy cells.
Also Read: Personalized Supplement Company Bioniq Raises $15M In Funds
Dr Zhavoronkov’s ultimate goal is to leverage AI to unravel the complex processes involved in aging. “Our number one priority is to teach AI to understand the basic biology of aging, and I think we’ve succeeded in that process. Now, we need to demonstrate that we can utilize this understanding to cure diseases,” he says.
Insilico Medicine’s AI-driven drugs showcase the massive untapped potential of artificial intelligence in all aspects of healthcare. As the company continues to innovate, its work brings hope to patients around the world and demonstrates that the future of medicine is promising, thanks to the application of the latest technological breakthroughs.
News
Alienware Just Announced Six New Gaming Monitors
The new models include three QD-OLED and three budget-friendly QHD options, expanding the company’s lineup for all gamers.
Alienware has just updated its gaming monitor lineup with six new additions, including the highly anticipated Alienware 27 4K QD-OLED Monitor. The latest wave of releases is set to reach more gamers than ever, offering high-end QD-OLED displays alongside more budget-friendly options.
The latest displays clearly show that the company is doubling down on QD-OLED with three new models sporting the technology. A redesigned Alienware 34 Ultra-Wide QD-OLED Monitor is also making a return, further refining what is already a fan-favorite display.
A Unified Design: The AW30 Aesthetic
All six monitors feature Alienware’s new AW30 design language, first introduced at CES. The AW30 aesthetic brings a futuristic, minimalist look that unites the entire lineup under a cohesive visual identity.
Pushing QD-OLED Even Further
The refreshed Alienware 34 Ultra-Wide QD-OLED Monitor (AW3425DW) builds on its predecessor’s success with a 240Hz refresh rate (up from 175Hz) and HDMI 2.1 FRL support. It also gains G-SYNC Compatible certification alongside AMD FreeSync Premium Pro and VESA AdaptiveSync, ensuring ultra-smooth performance. With a WQHD (3440×1440) resolution and an 1800R curve, this display enhances immersion for both gaming and cinematic experiences.
For those who crave speed, the Alienware 27 280Hz QD-OLED Monitor (AW2725D) pairs a high refresh rate with QHD resolution, balancing sharp visuals with ultra-smooth gameplay. Meanwhile, the Alienware 27 4K QD-OLED Monitor (AW2725Q) delivers stunning clarity with an industry-leading pixel density of 166 PPI, making it the sharpest OLED or QD-OLED monitor available.
Also Read: Infinite Reality Acquires Napster In $207 Million Deal
Worried about OLED burn-in? Alienware’s entire QD-OLED lineup comes with a three-year limited warranty covering burn-in concerns, offering peace of mind for gamers investing in these high-end displays.
Bringing QHD To A Wider Audience
Alongside QD-OLED, Alienware is also releasing three new QHD gaming monitors aimed at more price-conscious gamers. The Alienware 34 Gaming Monitor (AW3425DWM), Alienware 32 Gaming Monitor (AW3225DM), and Alienware 27 Gaming Monitor (AW2725DM) provide a range of sizes and formats to suit different preferences:
- The Alienware 34 Gaming Monitor (AW3425DWM): An ultrawide (WQHD) option for a panoramic, immersive experience.
- The Alienware 32 Gaming Monitor (AW3225DM): A standard 16:9 panel for a traditional but expansive desktop setup.
- The Alienware 27 Gaming Monitor (AW2725DM): A 27” display offering the same performance in a more compact form factor.
All three gaming monitors feature a fast 180 Hz refresh rate, a 1ms gray-to-gray response time, and support for NVIDIA G-SYNC, AMD FreeSync, and VESA AdaptiveSync to eliminate screen tearing. Additionally, with 95% DCI-P3 color coverage and VESA DisplayHDR400 certification, these displays deliver vibrant colors and high dynamic range for lifelike visuals.
Alienware Just Announced Six New Gaming Monitors
Infinite Reality Acquires Napster In $207 Million Deal
Tesla Announces Upcoming Saudi Arabia Debut On April 10
Warner Bros. Discovery Invests In OSN Streaming To Expand MENA Reach
